Natural Product (NP) Details
| General Information of the NP (ID: NP1829) | |||||
|---|---|---|---|---|---|
| Name |
Aloe emodin
|
||||
| Synonyms |
Aloe-emodin; Aloe emodin; 481-72-1; Aloeemodin; Aloe-emodine; Rhabarberone; 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione; 3-Hydroxymethylchrysazine; EMODINE; 3-Hydroxymethylchrysazin; 1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone; 1,8-Dihydroxy-3-hydroxymethylanthraquinone; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-; NSC 38628; 1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione; UNII-C8IYT9CR7C; C8IYT9CR7C; 3-(Hydroxymethyl)chrysazin; CHEMBL40275; CHEBI:2607; 1,8-dihydroxy-3-hydroxymethyl-anthraquinone; NSC38628; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone; MFCD00017373; SMR000470920; CCRIS 3526; EINECS 207-571-7; BRN 2059062; Aloe-emodol; Rottlerin?; Aloe-Emodine,(S); Aloe-emodin-[d5]; 1286579-72-3; DSSTox_CID_10695; DSSTox_RID_78855; DSSTox_GSID_30695; 4-08-00-03578 (Beilstein Handbook Reference); cid_10207; MLS000697563; MLS006011799; SCHEMBL309756; ANTHRAQUINONE, 1,8-DIHYDROXY-3-HYDROXYMETHYL-; Aloe-emodin, analytical standard; DTXSID2030695; Aloe-emodin, >=95% (HPLC); HMS3655N16; BCP28272; HY-N0189; ZINC4098644; Tox21_302400; AC-020; BBL027838; BDBM50085551; CA0128; LMPK13040002; NSC-38628; s2259; STL146380; AKOS005720864; CCG-208456; CS-3709; MCULE-6965338444; 9, 1,8-dihydroxy-3-(hydroxymethyl)-; SMP2_000291; NCGC00163510-01; NCGC00163510-02; NCGC00163510-03; NCGC00255349-01; AK160272; AS-11638; CAS-481-72-1; NCI60_003685; AB0010470; FT-0622062; N1851; SW219916-1; Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-; C10294; 481A721; Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-; SR-01000765772; Q-100526; Q3533249; SR-01000765772-3; 1,8-Dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #; 1,8-Dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9CI; 9,10-Anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)- (9CI); 9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene; Diacerein impurity B, European Pharmacopoeia (EP) Reference Standard; 1,8-Dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (Aloe-Emodin)
Click to Show/Hide
|
||||
| Species Origin | Senna occidentalis ... | Click to Show/Hide | |||
| Senna occidentalis | |||||
| Disease | Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C15H10O5
|
||||
| PubChem CID | |||||
| Canonical SMILES |
C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)CO
|
||||
| InChI |
1S/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H2
|
||||
| InChIKey |
YDQWDHRMZQUTBA-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 481-72-1
|
||||
| ChEBI ID | |||||
| Herb ID | |||||
| SymMap ID | |||||
| TCMSP ID | |||||
| TTD Drug ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Resistance can be Reversed by This NP | ||||||
| Doxorubicin | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Reversing Drug Resistance | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Down-regulation | Activity | ABCB1 | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Cleavage | CASP3 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | ||
| Experimental
Result(s) |
AE could be a potential reversal agent to resensitize ADR resistant in tumor chemotherapy. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Fatty aldehyde dehydrogenase (ALDH3A2) | Molecule Info | [3] | |
